Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverter-defibrillator aborted and unnecessary shocks

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 2, 2007, Pages 157-165

  Gunderson, Bruce D ^a   Abeyratne, Athula I ^a   Olson, Walter H ^a   Swerdlow, Charles D ^b  

^a MEDTRONIC INC   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Implantable cardioverter defibrillator (ICD); Shocks; Ventricular fibrillation

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DEFIBRILLATOR; ELECTRIC BATTERY; FEMALE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE PACING; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; TREATMENT FAILURE;

ALGORITHMS; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 33847380668     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00644.x     Document Type: Article

References (17)

1. Hurwitz JL, Hook BG, Flores BT, Marchlinski FE. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices. J Am Coll Cardiol 1993; 21:895-900.
2. Raedle-Hurst TM, Wiecha J, Schwab JO, Schmitt H, Hinrichs M, Tillmanns H, Waldecker B. Clinical performance of a specific algorithm to reconfirm self-terminating ventricular arrhythmias in current implantable cardioverter-defibrillators. Am J Cardiol 2001; 88:744-749.
3. Wilkoff BL, Ousdigian KT, Sterns LD,Wang ZJ,Wilson RD, Morgan JM, for the EMPIRIC Trial Investigators. Empiric versus physician-tailored programming of ICDs. J Am Coll Cardiol 2006; 48:330-339.
4. Wilkoff BL, Kuhlkamp V, Volosin K, Ellenbogen K, Waldecker B, Kacet S, Gillberg JM, et al. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: Results and technical considerations. Circulation 2001; 103: 381-386.
5. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: Results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 2005; 111:2898-2905.
6. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, et al. for the PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators. Circulation 2004; 100:2591-2596.
7. Nelson Wayne B. Recurrent Event Data Analysis for Product Repairs, Disease Recurrences, and Other Applications. ASA-SIAM Series on Statistics and Applied Probability, SIAM, Philadelphia, ASA, Alexandria, VA, 2002.
8. Swerdlow CD. Supraventricular tachycardia-ventricular tachycardia discrimination algorithms in implantable cardioverter defibrillators: State-of-the-art review. J Cardiovasc Electrophysiol 2001; 12:606-612.
9. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001; 104:796-801.
10. Physician's Manual for EnTrust ICD. Medtronic Inc., Minneapolis. 2005.
11. Wilkoff BL, Hess M, Young J, Abraham W. Differences in ICD utilization by primary and secondary prevention patients with cardiac resynchronization therapy indication. (abstract) Pacing Clin Electrophysiol 2003; 26:972.
12. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, et al. Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 28:3115-3123.
13. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.
14. Kadish A, Dyer A, Daubert JP, Quigg R, Estes M, Anderson KP, Calkins H, et al for the DEFINITE Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350:2151-2158.
15. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. for the SCD-HeFT Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237.
16. Buxton AE, Lee KL, DiCarlo L, Echt DS, Fisher JD, Greer GS, Josephson ME, et al. Nonsustained ventricular tachycardia in coronary artery disease: Relation to inducible sustained ventricular tachycardia. MUSTT Investigators. Ann Intern Med 1996; 125: 35-39.
17. Wilkoff BL, Stern R, Williamson B, Wathen M, Holloman K, Fieberg A, Brown M. Design of the primary prevention parameters evaluation (PREPARE) trial of implantable cardioverter defibrillators to reduce patient morbidity. Trials 2006; 7:18-25.